EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis

Zhongqiao Lin iD, Li Zhu, Yuyang Huang, Lizhu Chen iD, Yuping Lu, Yu Chen, Jing Lin

International Journal of Cancer · 2025

DOI: 10.1002/ijc.70254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Zhongqiao Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Phase I Clinical Trial Ward, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, …. Hauptthemen laut MEDLINE: Melanoma, Carcinoma, Skin Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Startup Fund for scientific research, Fujian Medical University, Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, Special Research Funds for Local Science and Technology Development Guided by Central Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical features, treatment efficacy, and prognostic differences in melanoma patients with cavity carcinomatosis, which is of rare occurrence, are still unclear. A retrospective analysis was conducted on melanoma patients with cavity carcinomatosis treated at Fujian Cancer Hospital from 2007 to 2023, with follow‐up ending in March 2024. The results showed that among 1430 melanoma patients, 79 had cavity carcinomatosis (5.5%). Median time to cavity carcinomatosis was 6.53 months (interquartile range: 0.23–26.20). The survival after melanoma cavity carcinomatosis was 5.23 months (95% CI: 4.39–6.07). Post‐cavity carcinomatosis survival improved to 6.30 months with treatment, versus 1.13 months without ( p = .001). Anti‐BRAF treatment did not outperform with only 4.83 months of progression‐free survival, and the objective response rate was 14.29%. The curative effect of chemotherapy and immunotherapy on BRAF wild‐type patients was similar. LDH levels strongly correlated with cavity carcinomatosis survival; patients with LDH ≤ ULN and ULN < LDH ≤ 2.5ULN lived longer than those with LDH > 2.5ULN (6.77 vs. 5.13 vs. 2.67 months, p = .008). This indicated that melanoma with cavity carcinomatosis should be considered a distinct subtype that signifies a high mortality rate. Continuous anti‐tumor therapy can still improve survival despite the lack of standout treatments after onset. Serum LDH levels hold the potential to serve as a crucial survival predictor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaCarcinomaSkin NeoplasmsHumansRetrospective StudiesFemaleMaleMiddle AgedAgedPrognosisAdultProto-Oncogene Proteins B-rafTreatment Outcome

Stichwörter der Autor:innen

cavity carcinomatosisclinical featuresmelanomasurvival outcomestreatment response

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Phase I Clinical Trial Ward, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou, China.
  • Clinical Oncology School of Fujian Medical University, Fuzhou, China.
  • Fuzhou University, Fuzhou, China.
  • Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou, China.
  • Cancer Bio-Immunotherapy Center, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou, China.

ORCID-Profile: Zhongqiao Lin, Lizhu Chen

Förderung

  • Startup Fund for scientific research, Fujian Medical University
  • Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province
  • Special Research Funds for Local Science and Technology Development Guided by Central Government
  • Joint Funds for the Innovation of Science and Technology, Fujian Province
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Lin, Z., Zhu, L., Huang, Y., Chen, L., Lu, Y., Chen, Y., & Lin, J. (2025). Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis. International Journal of Cancer. https://doi.org/10.1002/ijc.70254

Vancouver

Lin Z, Zhu L, Huang Y, Chen L, Lu Y, Chen Y, et al. Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis. International Journal of Cancer. 2025. doi:10.1002/ijc.70254

BibTeX
@article{Lin2025,
  author = {Lin, Zhongqiao and Zhu, Li and Huang, Yuyang and Chen, Lizhu and Lu, Yuping and Chen, Yu and Lin, Jing},
  title = {Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.70254}
}
Kostenlos starten →